Recently approved, by the Food and Drug Administration, Besremi has demonstrated to be effective and safe for patients with polycythemia vera — adding hope to their treatment regimen. The Food and ...
Rome, Italy - A new double-blind, placebo-controlled study has shown that low-dose aspirin can prevent thrombotic complications in patients with polycythemia vera, provided they have no ...
A recent study analyzed patient demographics, incidence, and geographic distribution of PV patients in Canada during a 19-year period. Significantly higher incidence rates compared with the national ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results